WHO ICTRP trial
Clinical Study on Xiao'er Huangjin Zhike Granules Combined with Ambroxol…
ChiCTR2500106802 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500106802 |
|---|---|
| Public title | Clinical Study on Xiao'er Huangjin Zhike Granules Combined with Ambroxol Hydrochloride in the Treatment of Infantile Acute Bronchitis |
| Scientific title | Clinical Study on Xiao'er Huangjin Zhike Granules Combined with Ambroxol Hydrochloride in the Treatment of Infantile Acute Bronchitis |
| Primary sponsor | Shanghai Children's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Acute bronchitis |
| Interventions | Experimental group:Xiao'er Huangjin Zhike Granules: For oral administration, 2 sachets each time, twice a day; Ambroxol Hydrochloride Oral Solution (trade name: Mucosolvan): For oral administration, 2.5ml (0.6%) each time, three times a… |
| Registration date | Jul 30, 2025 |
| Target size | Experimental group:60;Control group:60 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: